Avista Capital Partners’ sale of Inform Diagnostics produced a gross MOIC of 3x and gross IRR of 39%, according to an LP letter seen by Axios.
Why it matters: Upon completion of the deal, Avista expects to rake in an estimated $132 million in proceeds, or a total of $163 million when accounting for proceeds already received to date, and price adjustments.
